Sino Biological provides a comprehensive range of recombinant CEACAM proteins and corresponding CEACAM antibodies for crucial research, aiding investigations into CEACAM interactions with pathogens and their potential in new medical discoveries.
Sino Biological is focused on developing multi-pass transmembrane protein products and has set up three platforms to provide important raw materials for early-stage drug development. These platforms include virus-like particles (VLP), detergent micelle, and nanodisc.
The Beacon® single-cell optofluidic system can be used to accurately select single cells on a chip, perform multiple single-cell assays, and export target cells based on specific results. The Beacon® optofluidic platform preserves the diversity of B cells, generating high-quality positive hits at an early stage of discovery and avoiding the loss of “good clones”.
With 15+ years of experience in recombinant protein expression, Sino Biological has developed a proprietary mammalian transient expression platform, with both HEK293 and CHO cell lines used as major workhorses. Our platform enables the high-throughput delivery and the generation high-quality of recombinant proteins and antibodies that are widely used in applications such as antigen preparation, antibody discovery, protein str…
